Krystal Biotech

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell KRYS and other ETFs, options, and stocks.

About KRYS

Krystal Biotech, Inc. operates as a biotechnology company, which engages in developing and commercializing pharmaceutical products. It offers the product, VYJUVEK. 

CEO
Krish S. Krishnan
CEOKrish S. Krishnan
Employees
275
Employees275
Headquarters
Pittsburgh, Pennsylvania
HeadquartersPittsburgh, Pennsylvania
Founded
2016
Founded2016
Employees
275
Employees275

KRYS Key Statistics

Market cap
8.04B
Market cap8.04B
Price-Earnings ratio
41.47
Price-Earnings ratio41.47
Dividend yield
Dividend yield
Average volume
250.27K
Average volume250.27K
High today
$280.53
High today$280.53
Low today
$271.27
Low today$271.27
Open price
$271.27
Open price$271.27
Volume
360.03K
Volume360.03K
52 Week high
$295.98
52 Week high$295.98
52 Week low
$122.80
52 Week low$122.80

Stock Snapshot

With a market cap of 8.04B, Krystal Biotech(KRYS) trades at $276.45. The stock has a price-to-earnings ratio of 41.47.

During the trading session on 2026-02-14, Krystal Biotech(KRYS) shares reached a daily high of $280.53 and a low of $271.27. At a current price of $276.45, the stock is +1.9% higher than the low and still -1.5% under the high.

Trading volume for Krystal Biotech(KRYS) stock has reached 360.03K, versus its average volume of 250.27K.

The stock's 52-week range extends from a low of $122.80 to a high of $295.98.

The stock's 52-week range extends from a low of $122.80 to a high of $295.98.

KRYS News

Simply Wall St 19h
Does FDA RMAT Status For KB707 In Lung Cancer Change The Bull Case For Krystal Biotech?

In February 2026, Krystal Biotech announced that the FDA granted Regenerative Medicine Advanced Therapy (RMAT) designation to KB707, its inhaled, redosable immu...

Does FDA RMAT Status For KB707 In Lung Cancer Change The Bull Case For Krystal Biotech?
Simply Wall St 3d
Krystal Biotech RMAT Win For KB707 And What It Means For Valuation

Krystal Biotech received FDA Regenerative Medicine Advanced Therapy (RMAT) designation for KB707, an inhaled, redosable immunotherapy for advanced non small cel...

Krystal Biotech RMAT Win For KB707 And What It Means For Valuation
TipRanks 5d
Krystal Biotech granted RMAT designation for KB707 in NSCLC

Krystal Biotech (KRYS) announced that the United States Food and Drug Administration granted Regenerative Medicine Advanced Therapy designation to KB707, the Co...

Analyst ratings

100%

of 11 ratings
Buy
100%
Hold
0%
Sell
0%

People also own

Based on the portfolios of people who own KRYS. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.